Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:PBIONASDAQ:PRPONASDAQ:SQLNASDAQ:TLIS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumePBIOPressure BioSciences$0.00$0.00$0.00▼$0.21$110K-0.75,527 shsN/APRPOPrecipio$11.51+6.1%$8.41$3.90▼$11.80$17.09M1.289,575 shs5,550 shsSQLSeqLL$4.16$6.50▼$96.00$2.12M1.3452,119 shs1,731 shsTLISTalis Biomedical$1.75$1.53$1.04▼$9.35$3.19M1.32,805 shs3 shs2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformancePBIOPressure BioSciences0.00%0.00%-40.48%-81.48%-98.28%PRPOPrecipio+5.64%+6.07%+16.25%+69.75%+116.30%SQLSeqLL0.00%0.00%0.00%0.00%-15.91%TLISTalis Biomedical0.00%+24.11%+24.11%+0.57%-78.89%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationPBIOPressure BioSciencesN/AN/AN/AN/AN/AN/AN/AN/APRPOPrecipio1.6842 of 5 stars0.05.00.00.03.32.50.0SQLSeqLLN/AN/AN/AN/AN/AN/AN/AN/ATLISTalis BiomedicalN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PricePBIOPressure BioSciences 0.00N/AN/AN/APRPOPrecipio 0.00N/AN/AN/ASQLSeqLL 0.00N/AN/AN/ATLISTalis Biomedical 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookPBIOPressure BioSciences$1.98M0.05N/AN/A($1.29) per share0.00PRPOPrecipio$18.53M0.94N/AN/A$8.16 per share1.41SQLSeqLL$80K0.00N/AN/A$14.70 per share0.00TLISTalis Biomedical$300K10.63N/AN/A$37.95 per share0.05Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DatePBIOPressure BioSciences-$29.31M-$0.96N/A∞N/AN/AN/AN/AN/APRPOPrecipio-$4.29M-$2.07N/A∞N/A-15.45%-25.87%-17.93%8/11/2025 (Estimated)SQLSeqLL-$4.09M-$16.40N/AN/AN/AN/A-124.09%-64.18%N/ATLISTalis Biomedical-$62.01M-$28.02N/A∞N/AN/A-79.74%-57.16%8/18/2025 (Estimated)Latest PBIO, PRPO, TLIS, and SQL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025PRPOPrecipioN/A-$0.59N/A-$0.59N/A$4.93 million3/27/2025Q4 2024PRPOPrecipio$0.74-$0.23-$0.97-$0.23$8.01 million$5.45 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthPBIOPressure BioSciencesN/AN/AN/AN/AN/APRPOPrecipioN/AN/AN/AN/AN/ASQLSeqLLN/AN/AN/AN/AN/ATLISTalis BiomedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioPBIOPressure BioSciencesN/AN/AN/APRPOPrecipio0.030.760.57SQLSeqLL0.505.045.04TLISTalis BiomedicalN/A7.767.76Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipPBIOPressure BioSciences0.02%PRPOPrecipio10.45%SQLSeqLL1.82%TLISTalis Biomedical43.77%Insider OwnershipCompanyInsider OwnershipPBIOPressure BioSciences10.80%PRPOPrecipio16.90%SQLSeqLL22.30%TLISTalis Biomedical46.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionablePBIOPressure BioSciences1042.97 million38.33 millionNot OptionablePRPOPrecipio601.51 million1.26 millionNo DataSQLSeqLL7381,000296,000Not OptionableTLISTalis Biomedical2601.82 million984,000No DataPBIO, PRPO, TLIS, and SQL HeadlinesRecent News About These CompaniesBaker Bros. Advisors LP's Strategic Acquisition in Talis Biomedical CorpOctober 11, 2024 | finance.yahoo.comTalis Biomedical Agrees to Settle Investor Suit for $33 MillionOctober 3, 2024 | news.bloomberglaw.comTalis Biomedical Corp Ordinary SharesSeptember 17, 2024 | morningstar.comInsider Buying: Talis Biomedical Co. (NASDAQ:TLIS) Major Shareholder Buys 13,167 Shares of StockAugust 29, 2024 | insidertrades.comTalis Biomedical Shares Fall on Bankruptcy Filing, Delisting NoticeAugust 24, 2024 | marketwatch.comTLIS Stock Earnings: Talis Biomedical Reported Results for Q2 2024August 20, 2024 | investorplace.comTalis Biomedical Shares Tumble Premarket as Company Mulls BankruptcyAugust 7, 2024 | marketwatch.comWhy Talis Biomedical (TLIS) Stock Is Getting Obliterated TodayAugust 7, 2024 | benzinga.comWhy Is Talis Biomedical (TLIS) Stock Down 52% Today?August 7, 2024 | investorplace.com(TLIS) Trading ReportJuly 25, 2024 | news.stocktradersdaily.comTalis Biomedical Corp (TLIS)May 10, 2024 | investing.comTLIS Stock Earnings: Talis Biomedical Reported Results for Q1 2024May 8, 2024 | investorplace.comBragar Eagel & Squire is Investigating Certain Officers and Directors of Talis, TaskUs, and ...April 27, 2024 | eagletribune.comTalis Biomedical Corporation (TLIS)March 31, 2024 | finance.yahoo.comGrabar Law Office Investigates Claims on Behalf of Shareholders of Talis Biomedical CorporationFebruary 16, 2024 | markets.businessinsider.comTLIS Feb 2024 2.500 putFebruary 15, 2024 | finance.yahoo.comPeninsula diagnostics company to close Redwood City labs and offices, pursue 'strategic alternatives'November 14, 2023 | bizjournals.comTalis Biomedical Corporation: Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve CashNovember 14, 2023 | finanznachrichten.deLICY, BTAI and HROW among mid-day moversNovember 14, 2023 | msn.comTalis reviewing strategic alternatives, stock rallies 35%November 14, 2023 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePBIO, PRPO, TLIS, and SQL Company DescriptionsPressure BioSciences OTCMKTS:PBIO$0.0025 0.00 (0.00%) As of 06/20/2025Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia. The company's pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. It offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and the Shredder SG3. The company also distributes cell disruption equipment, parts, and consumables. In addition, it offers Barocycler consumable products, such as PCT MicroTubes, PCT MicroCaps, PCT-Micro Pestle, and pressure used to lyse samples for extraction tubes, as well as application specific kits, including consumable products and reagents. The company serves researchers at academic laboratories, government agencies, biotechnology companies, pharmaceutical firms, and other life science institutions. It has collaborations with RedShiftBio Inc.; Inova Schar Cancer Center; NYU; Leica Microsystems, GmbH; Steinbeis Centre for biopolymer analysis and biological mass spectrometry; The Ohio State University; University of Delaware; and Cedars Sinai Medical Center. The company was formerly known as Boston Biomedica, Inc. and changed its name to Pressure BioSciences, Inc. in September 2014. The company was incorporated in 1978 and is based in South Easton, Massachusetts.Precipio NASDAQ:PRPO$11.51 +0.66 (+6.07%) Closing price 06/20/2025 03:50 PM EasternExtended Trading$11.18 -0.33 (-2.90%) As of 06/20/2025 06:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.SeqLL NASDAQ:SQLSeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. It focus on development of scientific assets and novel intellectual property across multiple omics fields. The company's True Single Molecule Sequencing technology (tSMS) platform offers a single molecule solution for DNA and RNA sequencing through detection of nucleic acids to researchers for analyzing many billions of single molecules in a single experiment and generate accurate and reproducible data. It provide solutions for various applications, such as biomarker discovery and diagnostic assay developments including laboratories associated with universities, scientific research centers, government institutions, and biotechnology and pharmaceutical companies. In addition, the company has research and development agreement with U.S. Department of Justice's Federal Bureau of Investigation to evaluate and determine the forensic capabilities of direct RNA sequencing using tSMS platform; and research collaboration with True Bearing Diagnostics, Inc. performing tSMS on whole-blood RNA to identify transcripts associated with coronary artery disease. Further, it has collaboration agreement with The Bernstein Laboratory to address fundamental questions in chromatin biology and epigenetic regulation; The Ting Laboratory; The Jackson Laboratory for Genomic Medicine assisting in the development of new methods for chromatin interaction analysis in single nuclei, with single-molecule resolution; Weizmann Institute of Science for developed and applied innovative single-molecule technologies; and Tetracore, Inc. to provide with tSMS systems and onsite support. The company was founded in 2013 and is headquartered in Billerica, Massachusetts.Talis Biomedical NASDAQ:TLIS$1.75 0.00 (0.00%) As of 06/20/2025Talis Biomedical Corporation operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Smith & Wesson Stock Falls on Earnings Miss, Tariff Woes Marvell's New AI Chip Deals Capture Wall Street’s Attention Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer GE Aerospace Turns Engines Into Long-Term Profits 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
